Follow
QuiaPEG Pharmaceuticals Holding AB
Nasdaq First North GM (Sweden)
QuiaPEG Pharmaceuticals operates in medical technology. The company has developed a technological platform that is used to improve and develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.
Sector:
HEALTH CARE
>
Pharmaceuticals, Biotechnology & Life Sciences
Exercise
Price
1.20 SEK
Exercise period(s)
20 Jan - 17 Feb 2021
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
QUIA
SE0001384850
Nasdaq First North GM
Sweden (SE)
Details of share in QuiaPEG Pharmaceuticals Holding AB with ticker QUIA
Status
Active
Order book id
40YR
Amount of instruments
55 318 341
Par value
0.9000
Currency
SEK
Segment
First North
Type
Price
Pre-money valuation
Time
Files
Listing
21 Jun 2005
Direct listing of QuiaPEG Pharmaceuticals Holding AB on Spotlight
Type
Price
Pre-money valuation
Time
Files
Private placement
4.50 SEK
42.77M SEK
23 Dec 2005
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.50 SEK
6.23M SEK
14 Sep - 04 Oct 2006
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Directed issue
0.85 SEK
36.01M SEK
30 Jan 2008
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Non-cash issue
29 Mar 2017
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Private placement
1.85 SEK
38.89M SEK
01 Nov 2017
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Private placement
1.75 SEK
39.62M SEK
27 Apr 2018
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Private placement
3.40 SEK
97.38M SEK
01 Feb 2019
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Private placement
3.55 SEK
110.25M SEK
17 Jul 2019
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
1.75 SEK
56.34M SEK
25 Jun - 09 Jul 2020
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Convertible issue
2.41 SEK
13 Jul 2020
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Market move
21 Aug 2020
Listing of QuiaPEG Pharmaceuticals Holding AB on Nasdaq First North GM
Type
Ticker
ISIN
Market
OPTION
QUIA TO4
SE0014429239
Nasdaq First North GM
Sweden (SE)
Details of option in QuiaPEG Pharmaceuticals Holding AB with ticker QUIA TO4
Status
Active
Order book id
6UX3
Amount of instruments
5 365 859
Currency
SEK
Segment
First North
Trading period
14 Aug 2020 - 15 Feb 2021
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company during the subscription period from January 20, 2021 until February 17, 2021 at a subscription price corresponding to seventy (70) percent of the volume weighted average price of the Company's share during the period of ten (10) trading days ending one (1) banking day before the first day of the redemption period. However, the exercise price should not be less than SEK 1.0.
Update (04.08.2020): QuiaPEG's Rights issue registered - conversion of BTU into shares and warrants and admission to trading of warrants.
Update (21.08.2020): Trading in QuiaPEG's shares and warrants begins today on Nasdaq First North Growth Market Sweden.
Update (19.01.2021):
Type
Price
Pre-money valuation
Time
Files
Exercise
1.20 SEK
66.38M SEK
20 Jan - 17 Feb 2021
Option exercise terms for QUIA TO4
Type
Ticker
ISIN
Market
SHARE
VISY
SE0001384850
Nasdaq First North GM
Sweden (SE)
Details of share in QuiaPEG Pharmaceuticals Holding AB with ticker VISY
Status
Archived
Order book id
30329
Amount of instruments
Par value
Currency
SEK
Type
Price
Pre-money valuation
Time
Files
Listing
21 Jun 2005
Direct listing of QuiaPEG Pharmaceuticals Holding AB on Spotlight
Type
Price
Pre-money valuation
Time
Files
Private placement
4.50 SEK
42.77M SEK
23 Dec 2005
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.50 SEK
6.23M SEK
14 Sep - 04 Oct 2006
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Ticker
ISIN
Market
SHARE
LUCE
SE0001384850
Spotlight
Sweden (SE)
Details of share in QuiaPEG Pharmaceuticals Holding AB with ticker LUCE
Status
Archived
Order book id
30329
Amount of instruments
Par value
Currency
SEK
Type
Price
Pre-money valuation
Time
Files
Directed issue
0.85 SEK
36.01M SEK
30 Jan 2008
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Non-cash issue
29 Mar 2017
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Ticker
ISIN
Market
SHARE
QUIA
SE0001384850
Nasdaq First North GM
Sweden (SE)
Details of share in QuiaPEG Pharmaceuticals Holding AB with ticker QUIA
Status
Active
Order book id
40YR
Amount of instruments
55 318 341
Par value
0.9000
Currency
SEK
Segment
First North
Type
Price
Pre-money valuation
Time
Files
Private placement
1.85 SEK
38.89M SEK
01 Nov 2017
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Private placement
1.75 SEK
39.62M SEK
27 Apr 2018
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Private placement
3.40 SEK
97.38M SEK
01 Feb 2019
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Private placement
3.55 SEK
110.25M SEK
17 Jul 2019
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
1.75 SEK
56.34M SEK
25 Jun - 09 Jul 2020
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Convertible issue
2.41 SEK
13 Jul 2020
Share issue in QuiaPEG Pharmaceuticals Holding AB
Type
Price
Pre-money valuation
Time
Files
Market move
21 Aug 2020
Listing of QuiaPEG Pharmaceuticals Holding AB on Nasdaq First North GM
Type
Ticker
ISIN
Market
OPTION
QUIA TO4
SE0014429239
Nasdaq First North GM
Sweden (SE)
Details of option in QuiaPEG Pharmaceuticals Holding AB with ticker QUIA TO4
Status
Active
Order book id
6UX3
Amount of instruments
5 365 859
Currency
SEK
Segment
First North
Trading period
14 Aug 2020 - 15 Feb 2021
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company during the subscription period from January 20, 2021 until February 17, 2021 at a subscription price corresponding to seventy (70) percent of the volume weighted average price of the Company's share during the period of ten (10) trading days ending one (1) banking day before the first day of the redemption period. However, the exercise price should not be less than SEK 1.0.
Update (04.08.2020): QuiaPEG's Rights issue registered - conversion of BTU into shares and warrants and admission to trading of warrants.
Update (21.08.2020): Trading in QuiaPEG's shares and warrants begins today on Nasdaq First North Growth Market Sweden.
Update (19.01.2021):
Type
Price
Pre-money valuation
Time
Files
Exercise
1.20 SEK
66.38M SEK
20 Jan - 17 Feb 2021
Option exercise terms for QUIA TO4
People
Marcus Bosson
CEO
Steen Krøyer
Chairman of the board
Marek Kwiatkowski
Board member
Lars Linzander
Board member
Johan von Kantzow
Board member
Marcus Bosson
Board member
Mats Nilsson
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Virdings Allé 32 B
Zip code
754 50
City/district
Uppsala
Country
Sweden (SE)
Registration number
556658-0196
LEI code
967600JUP7EI6X9D2Z44
First trade date
21 Jun 2005
Company former names
Lucent Oil AB
07 Apr 2017
Viatech Systems AB
20 Aug 2007
Registration date
25 Mar 2004
Short name
QuiaPEG

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date